+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hormone Replacement Therapy (HRT) - Global Market Trajectory & Analytics

  • ID: 1946783
  • Report
  • September 2020
  • Region: Global
  • 93 Pages
  • Global Industry Analysts, Inc
1 of 2
Global Hormone Replacement Therapy (HRT) Market to Reach $10.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Hormone Replacement Therapy (HRT) estimated at US$7.6 Billion in the year 2020, is projected to reach a revised size of US$10.6 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027.

The U. S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 4.6% CAGR

The Hormone Replacement Therapy (HRT) market in the U. S. is estimated at US$2.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR. We bring years of research experience to this 17th edition of our report. The 93-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Abbott Laboratories
  • Allergan Plc
  • Bayer AG
  • Novartis AG
  • Noven Pharmaceuticals Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • TherapeuticsMD Inc.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
  • An Introduction to Menopause and Hormone Replacement Therapy
  • Recent Market Activity
  • The HRT Controversy - An Insight
  • Newer Studies Challenge WHI Findings and Re-establish Safety of HRT
  • Revised Recommendations of the NAMS and Endocrine Society
  • IMS Consensus Guidelines Paving Way for More Clarity of HRT
  • The Regional Divide
  • Increasing Number of Menopausal Women - A Major Market Driver
  • New Bioidentical Drugs Serve Unmet Market Needs
  • Generic Incursion in Hormone Replacement Therapy - List of Drugs With and Without Approved Generic Versions
  • Intense Competition Marks the Global HRT Market
  • The Premarin Saga
  • Estrace Cream Drives Revenue Gains in Allergan’s HRT Portfolio
  • Global Competitor Market Shares
  • Hormone Replacement Therapy (HRT) Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
2. FOCUS ON SELECT PLAYERS
  • Abbott Laboratories (USA)
  • Allergan Plc (Ireland)
  • Bayer AG (Germany)
  • Noven Pharmaceuticals, Inc. (USA)
  • Novartis AG(Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Orion Pharma AB (Finland)
  • Pfizer, Inc. (USA)
  • TherapeuticsMD, Inc. (USA)
3. MARKET TRENDS & DRIVERS
  • Unmet Needs in Combination Therapies for HRT drive Research for New Medicines
  • Topical Estrogens - More Safe and Effective
  • Transdermal HRT Products Present Exciting Opportunities
  • Phytoestrogens - The New Panacea for Menopausal Symptoms?
  • Diet Link to Menopause Symptoms Raises Interest
  • Impact of Soy and Other Phytoestrogens - A Reality Check
  • EstroG - A Successful Herbal Health Supplement in Alleviating Menopausal Symptoms
  • The Growing Buzz around Bioidentical Drugs
  • Bio-identical Hormones - A Natural and Safe Substitute to Synthetic HRT?
  • Pellet Therapy - A New Innovation Downsizes Conventional Issues with Bioidentical HRT
  • Direct-to-Consumer Advertising for HRT - A Mixed Bag
  • Estriol: The Next Generation Estrogen Therapy?
  • What Makes Estriol Work?
  • Topical Estriol - More Promising in Safety
  • Estriol - Used More Commonly Outside the US
  • Entry of Generics Threatens Market Growth Prospects
  • Are Non-Hormonal Therapies A Threat to HRT?
  • Earlier Failures Induce Lethargy in Non-Hormonal Therapies
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
  • TABLE 2: World Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
  • TABLE 3: World 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Hormone Replacement Therapy (HRT) Market Share (in %) by Company: 2020 & 2027
  • Market Analytics
  • TABLE 4: USA Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • TABLE 5: USA Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
CANADA
  • TABLE 6: Canada Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • TABLE 7: Canada Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
JAPAN
  • TABLE 8: Japan Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • TABLE 9: Japan Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
CHINA
  • TABLE 10: China Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • TABLE 11: China Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
EUROPE
  • Market Facts & Figures
  • European Hormone Replacement Therapy (HRT) Market: Competitor Market Share Scenario (in %) for 2020 & 2027
  • Market Analytics
  • TABLE 12: Europe Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
  • TABLE 13: Europe Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
  • TABLE 14: Europe 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
FRANCE
  • TABLE 15: France Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • TABLE 16: France Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
GERMANY
  • TABLE 17: Germany Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • TABLE 18: Germany Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
ITALY
  • TABLE 19: Italy Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • TABLE 20: Italy Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
UNITED KINGDOM
  • TABLE 21: UK Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • TABLE 22: UK Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
REST OF EUROPE
  • TABLE 23: Rest of Europe Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • TABLE 24: Rest of Europe Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
ASIA-PACIFIC
  • TABLE 25: Asia-Pacific Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • TABLE 26: Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
REST OF WORLD
  • TABLE 27: Rest of World Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • TABLE 28: Rest of World Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
IV. COMPETITION
  • Total Companies Profiled: 31
Note: Product cover images may vary from those shown
Adroll
adroll